DK161080C - Krystallinsk hydrat af oralt anvendeligt cephalosporin og praeparat dermed - Google Patents

Krystallinsk hydrat af oralt anvendeligt cephalosporin og praeparat dermed

Info

Publication number: DK161080C
Authority: DK; Denmark
Prior art keywords: crystallic; hydrate; preparation; oral; used cephalosporin
Prior art date: 1986-07-02

Application number

DK336487A

Other languages

Danish (da)

English (en)

Other versions

DK161080B (da

DK336487A (da

DK336487D0 (da

Inventor

Yoshio Hamashima

Kyoji Minami

Kyozo Kawata

Teruo Sakamoto

Toyohiko Takeda

Yusuke Suzuki

Masanori Tujikawa

Original Assignee

Shionogi & Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-07-02

Filing date

1987-06-30

Publication date

1991-11-11

1986-07-02 Priority claimed from JP61156954A external-priority patent/JP2544113B2/ja

1986-09-12 Priority claimed from JP21626086A external-priority patent/JPH0717651B2/ja

1987-06-30 Application filed by Shionogi & Co filed Critical Shionogi & Co

1987-06-30 Publication of DK336487D0 publication Critical patent/DK336487D0/da

1988-01-03 Publication of DK336487A publication Critical patent/DK336487A/da

1991-05-27 Publication of DK161080B publication Critical patent/DK161080B/da

1991-11-11 Application granted granted Critical

1991-11-11 Publication of DK161080C publication Critical patent/DK161080C/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cephalosporin Compounds (AREA)
Medicinal Preparation (AREA)

DK336487A 1986-07-02 1987-06-30 Krystallinsk hydrat af oralt anvendeligt cephalosporin og praeparat dermed DK161080C (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
JP15695486		1986-07-02
JP61156954A JP2544113B2 (ja)	1986-07-02	1986-07-02	安定なカプセル製剤
JP21626086A JPH0717651B2 (ja)	1986-09-12	1986-09-12	経口投与用セフアロスポリン水和物結晶
JP21626086		1986-09-12

Publications (4)

Publication Number	Publication Date
DK336487D0 DK336487D0 (da)	1987-06-30
DK336487A DK336487A (da)	1988-01-03
DK161080B DK161080B (da)	1991-05-27
DK161080C true DK161080C (da)	1991-11-11

Family

ID=26484565

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK336487A DK161080C (da)	1986-07-02	1987-06-30	Krystallinsk hydrat af oralt anvendeligt cephalosporin og praeparat dermed

Country Status (27)

Country	Link
US (2)	US4812561A (fi)
KR (1)	KR950005302B1 (fi)
CN (1)	CN1015106B (fi)
AR (1)	AR243893A1 (fi)
AT (1)	AT392472B (fi)
AU (1)	AU594167B2 (fi)
BE (1)	BE1001691A4 (fi)
CA (1)	CA1283405C (fi)
CH (1)	CH672788A5 (fi)
DE (1)	DE3721913A1 (fi)
DK (1)	DK161080C (fi)
ES (2)	ES2004952A6 (fi)
FI (1)	FI89052C (fi)
FR (1)	FR2601014B1 (fi)
GB (1)	GB2192183B (fi)
GR (1)	GR871014B (fi)
HK (1)	HK47893A (fi)
HU (1)	HU200777B (fi)
IE (1)	IE59613B1 (fi)
IL (1)	IL83059A (fi)
IT (1)	IT1211469B (fi)
NL (1)	NL193136C (fi)
NO (1)	NO170889C (fi)
NZ (1)	NZ220764A (fi)
PL (1)	PL159180B1 (fi)
RU (1)	RU1829932C (fi)
SE (1)	SE466257B (fi)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5089270A (en) *	1990-05-15	1992-02-18	L. Perrigo Company	Capsule-shaped tablet
NZ252433A (en) *	1992-04-30	1996-07-26	Schering Corp	Preparation of a dry hydrated cephalosporin powder formulation which is resistant to air oxidation and dehydration by mixing the drug with dry excipients and filling into a sealable storage container
ATE544789T1 (de) *	1998-10-27	2012-02-15	Westlake Longview Corp	Verfahren zur olefinpolymerisation, neue polyethylene und daraus hergestellte folien und artikel
US6544555B2 (en) *	2000-02-24	2003-04-08	Advancis Pharmaceutical Corp.	Antibiotic product, use and formulation thereof
US6565882B2 (en) *	2000-02-24	2003-05-20	Advancis Pharmaceutical Corp	Antibiotic composition with inhibitor
AT412213B (de) *	2000-05-30	2004-11-25	Sandoz Ag	Verfahren zur trocknung von amoxicillin oder amoxicillin-hältigen, oralen, festen pharmazeutischen zusammensetzungen unter verwendung eines gases mit einer definierten gasfeuchte
US6541014B2 (en) *	2000-10-13	2003-04-01	Advancis Pharmaceutical Corp.	Antiviral product, use and formulation thereof
US20020068078A1 (en) *	2000-10-13	2002-06-06	Rudnic Edward M.	Antifungal product, use and formulation thereof
US20020197314A1 (en) *	2001-02-23	2002-12-26	Rudnic Edward M.	Anti-fungal composition
US7842791B2 (en) *	2002-12-19	2010-11-30	Nancy Jean Britten	Dispersible pharmaceutical compositions
CA2533178C (en) *	2003-07-21	2014-03-11	Advancis Pharmaceutical Corporation	Antibiotic product, use and formulation thereof
US8313775B2 (en) *	2003-07-21	2012-11-20	Shionogi Inc.	Antibiotic product, use and formulation thereof
US8425936B2 (en) *	2003-07-21	2013-04-23	Shionogi Inc.	Antibiotic product, use and formulation thereof
JP2007502296A (ja) *	2003-08-11	2007-02-08	アドバンシスファーマスーティカルコーポレイション	ロバストペレット
CA2535398C (en) *	2003-08-12	2013-11-12	Advancis Pharmaceuticals Corporation	Antibiotic product, use and formulation thereof
AU2004270170B2 (en) *	2003-08-29	2011-01-27	Shionogi, Inc.	Antibiotic product, use and formulation thereof
WO2005027877A1 (en) *	2003-09-15	2005-03-31	Advancis Pharmaceutical Corporation	Antibiotic product, use and formulation thereof
WO2005062898A2 (en) *	2003-12-24	2005-07-14	Advancis Pharmaceutical Corporation	Enhanced absorption of modified release dosage forms
WO2006014427A1 (en) *	2004-07-02	2006-02-09	Advancis Pharmaceutical Corporation	Tablet for pulsed delivery
US20110104109A1 (en) *	2005-07-13	2011-05-05	Frank Bennett	Tetracyclic indole derivatives and their use for treating or preventing viral infections
CA2833706C (en)	2005-11-11	2014-10-21	Boehringer Ingelheim International Gmbh	Quinazoline derivatives for the treatment of cancer diseases
US8778924B2 (en) *	2006-12-04	2014-07-15	Shionogi Inc.	Modified release amoxicillin products
US8357394B2 (en)	2005-12-08	2013-01-22	Shionogi Inc.	Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) *	2006-05-05	2012-10-30	Shionogi Inc.	Pharmaceutical compositions and methods for improved bacterial eradication
AR062927A1 (es) *	2006-10-11	2008-12-17	Bayer Healthcare Ag	4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
MX2009006877A (es)	2006-12-22	2009-09-28	Schering Corp	Derivados indolicos con anillo unido en las posiciones 5,6 y metodos de uso de los mismos.
CN101611002A (zh) *	2006-12-22	2009-12-23	先灵公司	用于治疗或预防hcv和相关病毒感染的4,5-环化吲哚衍生物
AU2007339382B2 (en)	2006-12-22	2013-05-02	Merck Sharp & Dohme Llc	4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
AU2008295484B2 (en)	2007-08-29	2013-09-26	Merck Sharp & Dohme Llc	Substituted indole derivatives and methods of use thereof
AR068108A1 (es) *	2007-08-29	2009-11-04	Schering Corp	Derivados azaindol 2,3-sustituidos y una composicion farmaceutica
CN101842353A (zh) *	2007-08-29	2010-09-22	先灵公司	用于治疗病毒感染的2,3-取代的吲哚衍生物
JP5416708B2 (ja) *	2007-11-16	2014-02-12	メルク・シャープ・アンド・ドーム・コーポレーション	３−アミノスルホニル置換インドール誘導体およびそれらの使用方法
MX2010005356A (es) *	2007-11-16	2010-05-27	Schering Corp	Derivados de indol 3-heterociclico sustituidos y metodos de uso de los mismos.
CA2727620A1 (en) *	2008-06-13	2009-12-17	Schering Corporation	Tricyclic indole derivatives and methods of use thereof
TW201020238A (en)	2008-08-20	2010-06-01	Schering Corp	Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
JP5674661B2 (ja)	2008-08-20	2015-02-25	メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋＳｈａｒｐ＆ＤｏｈｍｅＣｏｒｐ．	エチニル置換ピリジンおよびピリミジン誘導体ならびにそれらのウイルス感染の治療における使用
TW201019939A (en)	2008-08-20	2010-06-01	Schering Corp	Azo-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
JP5731976B2 (ja)	2008-08-20	2015-06-10	メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋＳｈａｒｐ＆ＤｏｈｍｅＣｏｒｐ．	置換ピリジン誘導体および置換ピリミジン誘導体ならびにそれらのウイルス感染の治療における使用
AU2010253791A1 (en)	2009-05-29	2011-11-24	Merck Sharp & Dohme Corp.	Antiviral compounds composed of three linked Aryl moieties to treat diseases such as Hepatitis C
HRP20191005T1 (hr)	2009-07-06	2019-08-23	Boehringer Ingelheim International Gmbh	Postupak sušenja bibw2992, njegovih soli i čvrstih farmaceutskih formulacija koje sadrže taj djelatni sastojak
CA2782024A1 (en)	2009-11-25	2011-06-03	Schering Corporation	Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
EP2516430B1 (en)	2009-12-22	2014-11-05	Merck Sharp & Dohme Corp.	Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases
US9433621B2 (en)	2010-02-18	2016-09-06	Merck Sharp & Dohme Corp.	Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
EA201290882A1 (ru)	2010-03-09	2013-04-30	Мерк Шарп Энд Домэ Корп.	Конденсированные трициклические силильные соединения и способы их применения для лечения вирусных заболеваний
EP2566449B1 (en)	2010-05-04	2014-10-08	Mahmut Bilgic	Pharmaceutical compositions comprising ceftibuten
JP2013541499A (ja)	2010-07-26	2013-11-14	メルク・シャープ・エンド・ドーム・コーポレイション	置換されたビフェニレン化合物およびウイルス性疾患の治療のためのその使用方法
WO2012050848A1 (en)	2010-09-29	2012-04-19	Schering Corporation	Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
WO2012142075A1 (en)	2011-04-13	2012-10-18	Merck Sharp & Dohme Corp.	2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
US9061041B2 (en)	2011-04-13	2015-06-23	Merck Sharp & Dohme Corp.	2′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
WO2013033900A1 (en)	2011-09-08	2013-03-14	Merck Sharp & Dohme Corp.	Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
WO2013033901A1 (en)	2011-09-08	2013-03-14	Merck Sharp & Dohme Corp.	Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
WO2013033899A1 (en)	2011-09-08	2013-03-14	Merck Sharp & Dohme Corp.	Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
WO2013039876A1 (en)	2011-09-14	2013-03-21	Merck Sharp & Dohme Corp.	Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases
WO2013151518A1 (en) *	2012-04-04	2013-10-10	Mahmut Bilgic	Capsule formulations comprising ceftibuten
EP2815743A1 (en)	2013-06-21	2014-12-24	Sanovel Ilac Sanayi ve Ticaret A.S.	Ceftibuten formulations
WO2015065817A1 (en)	2013-10-30	2015-05-07	Merck Sharp & Dohme Corp.	Pseudopolymorphs of an hcv ns5a inhibitor and uses thereof
US9242965B2 (en)	2013-12-31	2016-01-26	Boehringer Ingelheim International Gmbh	Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors
CN103948932B (zh) *	2014-04-17	2016-03-16	海南日中天制药有限公司	一种头孢克肟组合物及其制备方法
EP3031450A1 (en)	2014-12-12	2016-06-15	Sanovel Ilac Sanayi ve Ticaret A.S.	Ceftibuten capsule compositions
CA3022684A1 (en)	2016-05-13	2017-11-16	Aeromics, Inc.	Crystals
JP7060245B2 (ja)	2016-06-30	2022-04-26	キューペックスバイオファーマ，インコーポレイテッド	ボロン酸誘導体およびその治療的使用
CN106397454B (zh) *	2016-08-30	2018-08-24	山东罗欣药业集团股份有限公司	一种抗感染药物头孢布烯晶型化合物及其组合物
CN106432271A (zh) *	2016-09-21	2017-02-22	临沂草之美医药科技有限公司	一种治疗外科手术感染的药物头孢布烯晶体化合物
CN106432270A (zh) *	2016-09-21	2017-02-22	临沂草之美医药科技有限公司	一种制备治疗外科手术感染的药物头孢布烯晶体化合物的方法
CN106432272A (zh) *	2016-09-21	2017-02-22	临沂草之美医药科技有限公司	一种制备治疗外科手术感染的药物头孢布烯晶体化合物的方法
CN106397457A (zh) *	2016-09-21	2017-02-15	临沂草之美医药科技有限公司	一种治疗外科手术感染的药物头孢布烯晶体化合物
US20240327426A1 (en) *	2021-07-01	2024-10-03	Qpex Biopharma, Inc.	Crystalline forms of ceftibuten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3819620A (en) *	1972-06-01	1974-06-25	Squibb & Sons Inc	7-(d-alpha-amino-1,4-cyclohexadien-1-ylacet-amido)desacetoxycephalosporanic acid dihydrate
JPS5726692A (en) *	1980-07-22	1982-02-12	Fujisawa Pharmaceut Co Ltd	Preparation of stable crystal of salt of ceftizoxime
DE3037997A1 (de) *	1980-10-08	1982-05-13	Bayer Ag	(beta) -lactamantibiotika, verfahren zu deren herstellung sowie sie enthaltende mittel
YU44680B (en) *	1982-07-30	1990-12-31	Glaxo Lab Ltd	Process for obtaining very pure amorphous form of cephuroxim axetile
AU575854B2 (en) *	1983-10-04	1988-08-11	Shionogi & Co., Ltd.	7beta-(carboxyalkenamido) cephalosporins
AU580855B2 (en) *	1985-03-29	1989-02-02	Shionogi & Co., Ltd.	Alkeneamidocephalosporin esters

1987
- 1987-06-19 NZ NZ220764A patent/NZ220764A/xx unknown
- 1987-06-26 NL NL8701507A patent/NL193136C/nl not_active IP Right Cessation
- 1987-06-26 GB GB8715064A patent/GB2192183B/en not_active Expired - Lifetime
- 1987-06-29 IE IE173887A patent/IE59613B1/en not_active IP Right Cessation
- 1987-06-29 GR GR871014A patent/GR871014B/el unknown
- 1987-06-30 SE SE8702705A patent/SE466257B/sv not_active IP Right Cessation
- 1987-06-30 DK DK336487A patent/DK161080C/da not_active IP Right Cessation
- 1987-06-30 NO NO872729A patent/NO170889C/no not_active IP Right Cessation
- 1987-07-01 AT AT1658/87A patent/AT392472B/de not_active IP Right Cessation
- 1987-07-01 HU HU872992A patent/HU200777B/hu unknown
- 1987-07-01 CH CH2482/87A patent/CH672788A5/de not_active IP Right Cessation
- 1987-07-01 US US07/068,333 patent/US4812561A/en not_active Expired - Lifetime
- 1987-07-01 FI FI872903A patent/FI89052C/fi not_active IP Right Cessation
- 1987-07-01 FR FR878709316A patent/FR2601014B1/fr not_active Expired - Lifetime
- 1987-07-01 IT IT8767566A patent/IT1211469B/it active Protection Beyond IP Right Term
- 1987-07-01 IL IL83059A patent/IL83059A/xx not_active IP Right Cessation
- 1987-07-01 PL PL1987266567A patent/PL159180B1/pl unknown
- 1987-07-02 AR AR87308050A patent/AR243893A1/es active
- 1987-07-02 CA CA000541183A patent/CA1283405C/en not_active Expired - Lifetime
- 1987-07-02 AU AU75040/87A patent/AU594167B2/en not_active Expired
- 1987-07-02 DE DE19873721913 patent/DE3721913A1/de not_active Withdrawn
- 1987-07-02 CN CN87105009A patent/CN1015106B/zh not_active Expired
- 1987-07-02 KR KR1019870007019A patent/KR950005302B1/ko not_active Expired - Lifetime
- 1987-07-02 BE BE8700740A patent/BE1001691A4/fr not_active IP Right Cessation
- 1987-07-02 ES ES8702189A patent/ES2004952A6/es not_active Expired
- 1987-11-02 ES ES8703123A patent/ES2008759A6/es not_active Expired
- 1987-12-30 RU SU874203950A patent/RU1829932C/ru active
1988
- 1988-11-21 US US07/275,093 patent/US4933443A/en not_active Expired - Lifetime
1993
- 1993-05-20 HK HK478/93A patent/HK47893A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
NO170889C (no)	1992-12-23
KR880001670A (ko)	1988-04-26
SE8702705D0 (sv)	1987-06-30
PL266567A1 (en)	1988-07-21
NO872729L (no)	1988-01-04
RU1829932C (ru)	1993-07-23
IT1211469B (it)	1989-11-03
GR871014B (en)	1987-11-02
IE871738L (en)	1988-01-02
CH672788A5 (fi)	1989-12-29
GB2192183A (en)	1988-01-06
IL83059A0 (en)	1987-12-31
ES2004952A6 (es)	1989-02-16
IT8767566A0 (it)	1987-07-01
NO170889B (no)	1992-09-14
NL8701507A (nl)	1988-02-01
SE8702705L (sv)	1988-01-03
IL83059A (en)	1992-03-29
IE59613B1 (en)	1994-03-09
NL193136C (nl)	1998-12-04
FI872903A0 (fi)	1987-07-01
KR950005302B1 (ko)	1995-05-23
AU7504087A (en)	1988-01-07
FR2601014A1 (fr)	1988-01-08
HU200777B (en)	1990-08-28
DK161080B (da)	1991-05-27
NL193136B (nl)	1998-08-03
US4933443A (en)	1990-06-12
ES2008759A6 (es)	1989-08-01
AR243893A1 (es)	1993-09-30
US4812561A (en)	1989-03-14
CN87105009A (zh)	1988-03-23
AU594167B2 (en)	1990-03-01
DK336487A (da)	1988-01-03
GB8715064D0 (en)	1987-08-05
AT392472B (de)	1991-04-10
HK47893A (en)	1993-05-27
NZ220764A (en)	1989-09-27
NO872729D0 (no)	1987-06-30
FI89052C (fi)	1993-08-10
BE1001691A4 (fr)	1990-02-13
ATA165887A (de)	1990-09-15
DK336487D0 (da)	1987-06-30
GB2192183B (en)	1990-05-16
DE3721913A1 (de)	1988-01-07
FI89052B (fi)	1993-04-30
PL159180B1 (pl)	1992-11-30
CN1015106B (zh)	1991-12-18
SE466257B (sv)	1992-01-20
HUT44257A (en)	1988-02-29
FI872903L (fi)	1988-01-03
FR2601014B1 (fr)	1990-09-14
CA1283405C (en)	1991-04-23

Publication	Publication Date	Title
DK161080C (da)	1991-11-11	Krystallinsk hydrat af oralt anvendeligt cephalosporin og praeparat dermed
DK263288D0 (da)	1988-05-13	Farmaceutisk praeparat af cefuroxim-axetil
LV5197A3 (lv)	1993-10-10	Kristaliskas sukralozes iegusanas panemiens
DK385388D0 (da)	1988-07-08	Anvendelse af 5ht-3-antagonister
DK208188A (da)	1988-10-17	Anvendelse af 17-ketosteroider
DK350489D0 (da)	1989-07-14	Elektrisk resonator og anvendelse af resonator
DK363887A (da)	1988-01-15	Anvendelse af bromcruptin
DK481987A (da)	1988-03-17	Keramisk skum og fremgangsmaade til fremstilling af keramisk genstand
DK549688A (da)	1989-04-02	Fremstilling af peptider
DK549087A (da)	1988-04-21	Gangliosidbeslaegtede forbindelser og fremgangsmaade til fremstilling af samme
DK108190A (da)	1990-05-01	Stereoselektiv fremstilling af 3-substituerede 4-(phenylanilo)piperidinforbindelser og derivater
DK119688A (da)	1988-09-07	23-oxo- (-keto-) og 23-imino-derivater af mono- og diepoxy-ll-f28249-forbindelser
DK115288A (da)	1988-09-06	Pesticid anvendelse af 2-phenylimidazolderivater samt 2-phenyl-imidazolderivater og fremgangsmaader til deres fremstilling
DK87888D0 (da)	1988-02-19	Terapeutisk anvendelse af tindijoddeuteroporfyrin
DK625684A (da)	1985-07-01	Praeparater af i vand tungtoploeselige anthelmintika og fremgangsmaadertil deres fremstilling
DK300488A (da)	1988-12-04	Mono- og polyhydroxyacylderivater af polyoxygenerede labdaner, deres fremstilling og anvendelse
DK446388A (da)	1989-02-12	Pyrazinoxidforbindelse af nf-1616 -904 og farmaceutisk praeparat indeholdende denne
DK295184D0 (da)	1984-06-15	Fremstilling af monoalkylerede dihydroxybenzener og derved fremstillede hidtil ukendte forbindelser
IT8722159A0 (it)	1987-10-06	Preparazione di polifluoroenolati
DK135387D0 (da)	1987-03-17	Fremstilling af proteiner
DK79886A (da)	1986-08-22	Krystallinsk form af 7-(dimethylaminomethylen)-amino-9a-methoxymitosan
DK689388D0 (da)	1988-12-09	Anvendelse af dihydropyridinderivater
DK151588D0 (da)	1988-03-18	Imidazol-2-thionpraeparat til mundskylning af reperfusionsskader
DK26986D0 (da)	1986-01-20	Sammenkobling af fortrinsvis langstrakte elementer
DK321986A (da)	1987-06-22	Fremstilling af proteiner

Legal Events

Date	Code	Title	Description
2007-07-16	PUP	Patent expired